http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11257374&dopt=Abstract
Twin studies of immunogenicity--determining the genetic
contribution to vaccine failure.
Tan PL, Jacobson RM, Poland GA, Jacobsen SJ, Pankratz VS.
Department of Paediatrics, National University Hospital, Singapore.
CONTEXT: Estimating the magnitude of the genetic contribution to the overall
variation of antibody levels among individuals should help clarify the role of
genetic association in the biological mechanism of vaccine response and failure.
This, in turn, should help guide the design of improved vaccines with enhanced
efficacy. OBJECTIVE: To explore the magnitude of genetic influence on antibody
levels following measles, mumps and rubella vaccines. DESIGN: Cross-sectional
survey study. SETTING: Olmsted County, Minnesota. PARTICIPANTS: Healthy
twin-pairs. Of the 100 twin-pairs enrolled, 45 were monozygotic. INTERVENTIONS:
Determinations of zygosity, vaccine status, and quantitative IgG to measles,
mumps, and rubella. Main outcome measure: Heritability (ratio of genetic
variance to total variance). RESULTS: The number of vaccine-doses, the age at
initial immunization, and the time between immunization and sampling did not
differ between monozygotic and dizygotic twin pairs. The genetic variance - the
variance in antibody levels presumably due to genetic effects - was 0.49 for
measles, 0.54 for mumps, and 0.13 for rubella. Heritability, the ratio of
genetic variance to total variance, was 88.5% for measles, with the lower bound
of a one-sided 95% confidence interval equal to 52.4%. The heritability was, for
mumps, 38.8% with a lower bound of 1.60%. The heritability for rubella was 45.7%
with a lower bound of 4.94%. CONCLUSION: Our data support the concept that
genetic influences play a substantial role in the variation of antibody levels
following immunization against measles and, to a lesser extent, mumps and
rubella.
Publication Types:
PMID: 11257374 [PubMed - indexed for MEDLINE]